BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/25/2021 9:46:23 AM | Browse: 659 | Download: 1715
 |
Received |
|
2021-02-07 17:12 |
|
Peer-Review Started |
|
2021-02-07 17:16 |
|
First Decision by Editorial Office Director |
|
2021-04-05 17:08 |
|
Return for Revision |
|
2021-04-05 17:08 |
|
Revised |
|
2021-04-07 16:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-05-27 11:35 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-05-27 12:18 |
|
Articles in Press |
|
2021-05-27 12:18 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-06-19 09:00 |
|
Publish the Manuscript Online |
|
2021-06-25 09:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Hepatitis delta virus: From infection to new therapeutic strategies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Grazia A Niro, Arianna Ferro, Francesca Cicerchia, Isabella Brascugli and Marilena Durazzo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marilena Durazzo, MD, Associate Professor, Department of Medical Sciences, University of Turin, C So AM Dogliotti 14, Turin 10126, Italy. marilena.durazzo@unito.it |
| Key Words |
Hepatitis delta virus; Hepatitis B virus; Myrcludex; Lonafarnib; REP 2139 |
| Core Tip |
The hepatitis delta virus (HDV) is a small defective virus, of interest to scientists for its replicative reliance on and ability to inhibit the common hepatitis B virus (HBV). HDV infection occurs worldwide but shows some geographic variation and its prevalence is generally underestimated. HDV/HBV co-infection causes severe liver disease and the persistence of viral replication is associated with poor prognosis, although interferon is effective in around a quarter of patients. Improved understanding of the HDV life cycle has led to identification of specific antiviral targets and new drugs, including inhibitors of the sodium tauro-cholate cotransporting polypeptide receptor and farnesyltransferase. |
| Publish Date |
2021-06-25 09:46 |
| Citation |
Niro GA, Ferro A, Cicerchia F, Brascugli I, Durazzo M. Hepatitis delta virus: From infection to new therapeutic strategies. World J Gastroenterol 2021; 27(24): 3530-3542 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i24/3530.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i24.3530 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
